<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28835799</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1948-5875</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>8</Issue><PubDate><Year>2017</Year><Month>Aug</Month><Day>10</Day></PubDate></JournalIssue><Title>ACS medicinal chemistry letters</Title><ISOAbbreviation>ACS Med Chem Lett</ISOAbbreviation></Journal><ArticleTitle>Discovery of Potent EV71 Capsid Inhibitors for Treatment of HFMD.</ArticleTitle><Pagination><StartPage>841</StartPage><EndPage>846</EndPage><MedlinePgn>841-846</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acsmedchemlett.7b00188</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is a major causative agent of hand, foot, and mouth disease (HFMD), which can spread its infections to the central nervous and other systems with severe consequences. The viral caspid protein VP1 is a well-known target for antiviral efficacy because its occupancy by suitable compounds could stabilize the virus capsid, thus preventing uncoating of virus for RNA release. In this Letter, design, synthesis, and biological evaluation of novel anti-EV71 agents (aminopyridyl 1,2,5-thiadiazolidine 1,1-dioxides) are described. One of the most promising compounds (<b>14</b>) showed excellent antiviral activity against EV71 (EC<sub>50</sub> = 4 nM) and exhibited excellent <i>in vivo</i> efficacy in the EV71 infected mouse model.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian 361102, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Haiying</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Xuyang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Chunyan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Ya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Fusen</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Zhengxian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Deming</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xinsheng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Guoping</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shuhui</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>WuXi AppTec (Shanghai) Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Jiangsu Kanion Pharmaceutical Co., Ltd., 58 Haichangnan Road, Lianyungang 222001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhenzhong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Jiangsu Kanion Pharmaceutical Co., Ltd., 58 Haichangnan Road, Lianyungang 222001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Qingming</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Jiangsu Kanion Pharmaceutical Co., Ltd., 58 Haichangnan Road, Lianyungang 222001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Xiujuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Jiangsu Kanion Pharmaceutical Co., Ltd., 58 Haichangnan Road, Lianyungang 222001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Xuyang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian 361102, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Tianwei</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian 361102, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Med Chem Lett</MedlineTA><NlmUniqueID>101521073</NlmUniqueID><ISSNLinking>1948-5875</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HFMD</Keyword><Keyword MajorTopicYN="N">capsid inhibitor</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword></KeywordList><CoiStatement>The authors declare no
competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>8</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28835799</ArticleId><ArticleId IdType="pmc">PMC5554915</ArticleId><ArticleId IdType="doi">10.1021/acsmedchemlett.7b00188</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yang Y.; Wang H.; Gong E.; Du J.; Zhao X.; McNutt M. A.; Wang S.; Zhong Y.; Gao Z.; Zheng J. N. Neuropathology in 2 cases of fatal enterovirus type 71 infection from a recent pidemic in the People&#x2019;s Republic of China: a histopathologic, immunohistochemical, and reverse transcription polymerase chain reaction study. Hum. Pathol. 2009, 40, 1288.10.1016/j.humpath.2009.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2009.01.015</ArticleId><ArticleId IdType="pubmed">19386354</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.; Zhu Z.; Yang W.; Ren J.; Tan X.; Wang Y.; Mao N.; Xu S.; Zhu S.; Cui A.; Zhang Y.; Yan D.; Li Q.; Dong X.; Zhang J.; Zhao Y.; Wan J.; Feng Z.; Sun J.; Wang S.; Li D.; Xu W. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of Hand Foot and Mouth Disease in Fuyang city of China. Virol. J. 2010, 7, 94.10.1186/1743-422X-7-94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-94</ArticleId><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.; Yang B.; Zhai Y.; Yin Z.; Sun Y.; Rao Z. Peptidyl Aldehyde NK-1.8k Suppresses Enterovirus 71 and Enterovirus 68 Infection by Targeting Protease 3C. Antimicrob. Agents Chemother. 2015, 59, 2636.10.1128/AAC.00049-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00049-15</ArticleId><ArticleId IdType="pmc">PMC4394787</ArticleId><ArticleId IdType="pubmed">25691647</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J.; He Y. Q.; Yi L. N.; Zan H.; Kung H. F.; He M. L. Viral kinetics of Enterovirus 71 in human abdomyosarcoma cells. World J. Gastroenterol. 2011, 17, 4135.10.3748/wjg.v17.i36.4135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v17.i36.4135</ArticleId><ArticleId IdType="pmc">PMC3203367</ArticleId><ArticleId IdType="pubmed">22039330</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P.; Yang B.; Hao F.; Wang P.; He H.; Huang L.; Zhang X.; Zhang S.; Peng X.; Yin K.; Hu J.; Chen X.; Gu Z.; Wang L.; Shen L.; Hu G.; Li N.; Li J.; Chen S.; Xiao W.; Wang Z.; Guo G.; Chang X.; Zhang L.; Cai Q.; Lin T. Design, Synthesis, and Biological Evaluation of anti-EV71 Agents. Bioorg. Med. Chem. Lett. 2016, 26, 3346.10.1016/j.bmcl.2016.05.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2016.05.036</ArticleId><ArticleId IdType="pubmed">27234148</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth M. S.; Martin J. H. Picornavirus uncoating. Mol. Pathol. 2002, 55, 214.10.1136/mp.55.4.214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/mp.55.4.214</ArticleId><ArticleId IdType="pmc">PMC1187181</ArticleId><ArticleId IdType="pubmed">12147709</ArticleId></ArticleIdList></Reference><Reference><Citation>Pevear D. C.; Tina M. T.; Martin E. S.; James M. G. Activity of pleconaril against enteroviruses. Antimicrob. Agents Chemother. 1999, 43, 2109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89431</ArticleId><ArticleId IdType="pubmed">10471549</ArticleId></ArticleIdList></Reference><Reference><Citation>Shia K. S.; Li W. T.; Chang C. M.; Hsu M. C.; Chern J. H.; Leong M. K.; Tseng S. N.; Lee C. C.; Lee Y. C.; Chen S. J.; Peng K. C.; Tseng H. Y.; Chang Y. L.; Tai C. L.; Shih S. R. Design, Synthesis, and Structure-Activity Relationship of Pyridyl Imidazolidinones: A Novel Class of Potent and Selective Human Enterovirus 71 Inhibitors. J. Med. Chem. 2002, 45, 1644.10.1021/jm010536a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm010536a</ArticleId><ArticleId IdType="pubmed">11931618</ArticleId></ArticleIdList></Reference><Reference><Citation>Chern J. H.; Chang C. S.; Tai C. L.; Lee Y. C.; Lee C. C.; Kang I. J.; Lee C. Y.; Shih S. R. Synthesis and antipicornavirus activity of (R)- and (S)-1-[5-(40-chlorobiphenyl-4-yloxy)-3-methylpentyl]-3-pyridin-4-yl-imidazolidin-2-one. Bioorg. Med. Chem. Lett. 2005, 15, 4206&#x2013;4211. 10.1016/j.bmcl.2005.06.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2005.06.069</ArticleId><ArticleId IdType="pubmed">16054357</ArticleId></ArticleIdList></Reference><Reference><Citation>De Colibus L.; Wang X.; John A. B. S.; James K.; Ren J.; Jonathan G.; Gerhard P.; Nicola S.; Thomas S. W.; Hu Z.; Wang J.; Li X.; Peng W.; David J. R.; Elizabeth E. F.; Rao Z.; David I. S. More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules. Nat. Struct. Mol. Biol. 2014, 21, 282.10.1038/nsmb.2769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2769</ArticleId><ArticleId IdType="pmc">PMC4530014</ArticleId><ArticleId IdType="pubmed">24509833</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X.; Peng W.; Ren J.; Hu Z.; Xu J.; Lou Z.; Li X.; Yin W.; Shen X.; Claudine P.; Thomas S.; Walter; Gwyndaf E.; Danny A.; Robin O.; David J. R.; Wang J.; David I. S.; Elizabeth E. F.; Rao Z. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat. Struct. Mol. Biol. 2012, 19, 424.10.1038/nsmb.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2255</ArticleId><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Compounds 5 and 10&#x2013;18 were reported in WO2015165340.</Citation></Reference><Reference><Citation>Chang C. S.; Lin Y. T.; Shih S. R.; Lee C. C.; Lee Y. C.; Tai C. L.; Tseng S. N.; Chern J. H. Design, Synthesis, and Antipicornavirus Activity of 1-[5-(4-Arylphenoxy)alkyl]-3-pyridin-4-ylimidazolidin-2-one Derivatives. J. Med. Chem. 2005, 48, 3522.10.1021/jm050033v.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm050033v</ArticleId><ArticleId IdType="pubmed">15887961</ArticleId></ArticleIdList></Reference><Reference><Citation>Chern J. H.; Lee C. C.; Chang C. S.; Lee Y. C.; Tai C. L.; Lin Y. T.; Shia K. S.; Lee C. Y.; Shih S. R. Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones. Bioorg. Med. Chem. Lett. 2004, 14, 5051.10.1016/j.bmcl.2004.07.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2004.07.084</ArticleId><ArticleId IdType="pubmed">15380197</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J.; Yang Y.; Xu Y.; Ma C.; Qin C.; Zhang L. Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication. Virol. J. 2011, 8, 483.10.1186/1743-422X-8-483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-483</ArticleId><ArticleId IdType="pmc">PMC3212826</ArticleId><ArticleId IdType="pubmed">22029605</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.; Yu C. Animal models of enterovirus 71 infection: applications and limitations. J. Biomed. Sci. 2014, 21, 31.10.1186/1423-0127-21-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-31</ArticleId><ArticleId IdType="pmc">PMC4013435</ArticleId><ArticleId IdType="pubmed">24742252</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>